Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas W Mapel

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Best Practice & Research. Clinical Gastroenterology|November 5, 2013
Functional disorders of the gastrointestinal tract: Cost effectiveness reviewDouglas W Mapel
COPD|March 17, 2007
Estimating the cost of COPD--a matter of perspectiveDouglas W Mapel
Chest|August 11, 2004
Treatment implications on morbidity and mortality in COPDDouglas W Mapel
Thorax|April 15, 2010
Improved survival in COPD: reasons for hopeDouglas W Mapel
American Journal of Epidemiology|July 5, 2012
Limited lung function: impact of reduced peak expiratory flow on health status, health-care utilization, and expected survival in older adultsMelissa H Roberts, Douglas W Mapel
Drugs|May 7, 2014
Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness researchDouglas W Mapel, Melissa H Roberts
Pharmacoeconomics|August 3, 2012
New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analysesDouglas W Mapel, Melissa H Roberts
Current Opinion in Pulmonary Medicine|February 8, 2003
Undiagnosed airflow obstruction: prevalence and implicationsDavid B Coultas, Douglas W Mapel
International Journal of Chronic Obstructive Pulmonary Disease|March 22, 2013
Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPDDouglas W Mapel, Jenõ P Marton
COPD|December 2, 2006
Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999Douglas W Mapel, David Dedrick, Kourtney Davis
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Best Practice & Research. Clinical Gastroenterology|November 5, 2013
Functional disorders of the gastrointestinal tract: Cost effectiveness reviewDouglas W Mapel
COPD|March 17, 2007
Estimating the cost of COPD--a matter of perspectiveDouglas W Mapel
Chest|August 11, 2004
Treatment implications on morbidity and mortality in COPDDouglas W Mapel
Thorax|April 15, 2010
Improved survival in COPD: reasons for hopeDouglas W Mapel
American Journal of Epidemiology|July 5, 2012
Limited lung function: impact of reduced peak expiratory flow on health status, health-care utilization, and expected survival in older adultsMelissa H Roberts, Douglas W Mapel
Drugs|May 7, 2014
Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness researchDouglas W Mapel, Melissa H Roberts
Pharmacoeconomics|August 3, 2012
New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analysesDouglas W Mapel, Melissa H Roberts
Current Opinion in Pulmonary Medicine|February 8, 2003
Undiagnosed airflow obstruction: prevalence and implicationsDavid B Coultas, Douglas W Mapel
International Journal of Chronic Obstructive Pulmonary Disease|March 22, 2013
Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPDDouglas W Mapel, Jenõ P Marton
COPD|December 2, 2006
Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999Douglas W Mapel, David Dedrick, Kourtney Davis
Pageof 6